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Hyperpigmentation believed to be due to melanin, is a 
feature of chronic liver disease, especially primary bili-
ary cirrhosis and hemochromatosis. Normal plasma con-
centrations of immunoreactive P-melanocyte-stimulat-
ing hormone (p-MSH) h ave been found in both these 
conditions; thus elevation of plasma P-MSH plays no role 
in the pathogenesis of hepatic pigmentation. Normal 
levels are also fo und in hepatocellular failure, which 
supports the hypothesis that the kidney and not the liver 
is the site of metabolism of this hormone. 
Elevation of plasma immunoreactive P-melanocyte-stimulat-
ing hormone (P-MSH) is assoc iated with increased cutaneous 
melanin pigmentation in Addison's disease, Cushing's syn-
drome, postbilateral adrenalectomy [1) and chronic renal failure 
[2]. The pigmentation found in chronic liver disease, particu-
larly primary biliary cinhosis, is similarly believed to be due to 
increased melan·in in the skin. In idiopathic hemochromatosis, 
melanin deposition is a lso a major factor [3], although iron 
deposition may contribute to the characteristic slate-grey color. 
Why melanin deposition is excessive in liver disease is uncertain 
and in the present study we investigated th e association be-
tween cutaneous pigmentation and levels of plasma immuno-
reactive P-MSH in 13 patients with primary bilia1·y cirrhosis 
and 13 patients with idiopathic hemochromatosis. Levels in 
patients with fulminant hepatic failure have also been measured 
to determine whether the metabolism of this hormone is af-
fected by severe li ver impa irment, since the current evidence 
suggests that it is meta bolised solely by the kidney [ 4). 
MATERIALS AND METHODS 
T hirteen patien ts (11 fema le, 2 male) with primru·y bi lia ry cirrhosis 
in whom skin pigmentation was marked and generalized were studied. 
The d iagnosis had been made 6 mo to 6 y r earlier (mean 2.8 yr) . Liver 
biopsy showed that t he hepatic lesion had reached the cirrhotic stage 
in 11. Of the 13 patients (12 male, 1 female ) with idiopathic hemochro-
matosis, 4 were newly diagnosed and had genera lized greyish brown 
pigmentat ion especia lly of t he face, forearms and shins. The remaining 
9 patients had completed a course of venesection t he rapy from l to 17 
y r previous ly and had no residua l p igmentation. Liver biopsy showed 
cirrhosis in 8 patients with porta l fibrosis in t he remainder. The causes 
of t he hepatic necros is in the 11 patients with fulminant hepatic fa ilure, 
most of whom were abnormally pigmented , were suicidal paracetamol 
overdose [ 4), viral hepatitis [5] and dl·ug hypersensitivity [1]. All these 
patients were in grade 4 hepatic coma of at least 48 hr durat ion at the 
time of investigation. 
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Abbreviation: 
,8-MS H : ,8-melanocyte-stimulating hormone 
• S mi th, AG, i?huster, S : Unpu blished observations. 
P lasma immunoreactive ,8-MSH levels were m easured as previously 
described [6] both in these patien ts and in 55 normal cont rols. 
RESULTS 
The mean plasma ,8-MSH concentrations in the patients with 
primary biliary cirrhosis was 19.8 ± SE 4.0 ng/ l, in t hose with 
idiopa thic hemochromatosis 17.6 ± SE 2.8 ng/1, and in those 
with fulminant hepatic failure 16.8 ± SE 4.5 ng/ 1 (Figure). 
These values do not differ significantly from the mean of 16.2 
± 1.2 ng/l found in 55 normal controls. In only 4 subjects, 1 
with idiopathic hemochl'Omatosis and a plasma level of ,8-MSH 
of 43 ng/ 1, 2 with primary biliary cirrhosis (45 ng/ 1 and 46 ng/ 1), 
and 1 with fulminant h epatic failure (58 ng/1) were levels a bove 
the upper limit of normal (35 ng/ 1) for th e laboratory. In none 
of these was there evidence of renal failure . 
DISCUSSION 
The results show that the hyperpigmentation of primary 
biliary cirrhosis and hemochromatosis is not associated with 
elevation of plasma immunoreactive P-MSH. As discussed else-
where [5], elevation of plasma immunoreactive ,8-MSH is a rare 
association of pathological pigmentation. Normal plasma levels 
occur in the pigmentation of oral contraceptive therapy [7] ; 
phenothiazine [8), phenytoin and doxorubicin treatment*; ac-
romegaly and thyrotoxicosis [5]; in systemic sclerosis [9); and 
in many cases of the hyperpigmentation of malignancy and 
cachexia*. Indeed in Cushing's syndrome, postbilateral adre-
nalectomy, pigmentation may be absent even in the presence of 
considerable elevation of plasma immunoreactive P-MSH. • 
This accords with the view that in plasma the ,8-MSH sequence 
only 'occurs as a part of 2 molecules of far less pigmentary 
potency, P- and y-lipotropin [10], which cross-react with P-
MSH in most immunoassays [11]. 
It is also clear from our findings t hat patients with fulminant 
hepatic failure have normal levels of plasma immunoreactive 
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,8-MSH, suggesting that the liver is not involved in the metab-
olism of these peptides. 
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Announcement 
The Linnean Society of London in conjunction with the Brit ish Association of Dermatologists will 
hold an international symposium on the Skin of Vertebrates at Queen Elizabeth College (University of 
London), Campden Hill Road, London, W.8. September 25-27, 1978. 
· The convenors will be Dr. R. I. c_ Spearman and Dr. P. A. Riley, and the meeting will include 
speakers on epidermal structure and function , keratinization, development of pigmentation, modulation, 
proliferation and differentiation of skin cells and neurosensory function. Details may be obtained from 
Mr. T _ O'Grady, Linnean Society of London, Burlington House, Piccadilly, London WlV OLQ. 
